186 related articles for article (PubMed ID: 28586789)
1. The Effect of Positive SWOG Treatment Trials on Survival of Patients With Cancer in the US Population.
Unger JM; LeBlanc M; Blanke CD
JAMA Oncol; 2017 Oct; 3(10):1345-1351. PubMed ID: 28586789
[TBL] [Abstract][Full Text] [Related]
2. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
3. Population, Clinical, and Scientific Impact of National Cancer Institute's National Clinical Trials Network Treatment Studies.
Unger JM; LeBlanc M; George S; Wolmark N; Curran WJ; O'Dwyer PJ; Schnall MD; Mannel RS; Mandrekar SJ; Gray RJ; Zhao F; Bah M; Vaidya R; Blanke CD
J Clin Oncol; 2023 Apr; 41(11):2020-2028. PubMed ID: 36480773
[TBL] [Abstract][Full Text] [Related]
4. Adolescent and young adult enrollment to a National Cancer Institute-sponsored National Clinical Trials Network Research Group over 25 years.
Unger JM; Beauchemin M; Hershman DL
Cancer; 2021 Dec; 127(24):4574-4584. PubMed ID: 34351619
[TBL] [Abstract][Full Text] [Related]
5. Association of National Cancer Institute-Sponsored Clinical Trial Network Group Studies With Guideline Care and New Drug Indications.
Unger JM; Nghiem VT; Hershman DL; Vaidya R; LeBlanc M; Blanke CD
JAMA Netw Open; 2019 Sep; 2(9):e1910593. PubMed ID: 31483471
[TBL] [Abstract][Full Text] [Related]
6. Comparison of survival outcomes among cancer patients treated in and out of clinical trials.
Unger JM; Barlow WE; Martin DP; Ramsey SD; Leblanc M; Etzioni R; Hershman DL
J Natl Cancer Inst; 2014 Mar; 106(3):dju002. PubMed ID: 24627276
[TBL] [Abstract][Full Text] [Related]
7. A New Framework for Patient Engagement in Cancer Clinical Trials Cooperative Group Studies.
Deverka PA; Bangs R; Kreizenbeck K; Delaney DM; Hershman DL; Blanke CD; Ramsey SD
J Natl Cancer Inst; 2018 Jun; 110(6):553-559. PubMed ID: 29684151
[TBL] [Abstract][Full Text] [Related]
8. Disparities by Race, Age, and Sex in the Improvement of Survival for Major Cancers: Results From the National Cancer Institute Surveillance, Epidemiology, and End Results (SEER) Program in the United States, 1990 to 2010.
Zeng C; Wen W; Morgans AK; Pao W; Shu XO; Zheng W
JAMA Oncol; 2015 Apr; 1(1):88-96. PubMed ID: 26182310
[TBL] [Abstract][Full Text] [Related]
9. Enrollment of adolescents and young adults onto SWOG cancer research network clinical trials: A comparative analysis by treatment site and era.
Roth ME; Unger JM; O'Mara AM; Lewis MA; Budd T; Johnson RH; Pollock BH; Blanke C; Freyer DR
Cancer Med; 2020 Mar; 9(6):2146-2152. PubMed ID: 32009305
[TBL] [Abstract][Full Text] [Related]
10. Return on investment: a fuller assessment of the benefits and cost savings of the US publicly funded family planning program.
Frost JJ; Sonfield A; Zolna MR; Finer LB
Milbank Q; 2014 Dec; 92(4):696-749. PubMed ID: 25314928
[TBL] [Abstract][Full Text] [Related]
11. Overview of the epidemiology methods and applications: strengths and limitations of observational study designs.
Colditz GA
Crit Rev Food Sci Nutr; 2010; 50 Suppl 1(s1):10-2. PubMed ID: 21132580
[TBL] [Abstract][Full Text] [Related]
12. Analysis of Maryland cancer patient participation in National Cancer Institute-supported cancer treatment clinical trials.
Baquet CR; Ellison GL; Mishra SI
J Health Care Poor Underserved; 2009 May; 20(2 Suppl):120-34. PubMed ID: 19711497
[TBL] [Abstract][Full Text] [Related]
13. Italian cancer figures, report 2012: Cancer in children and adolescents.
; ;
Epidemiol Prev; 2013; 37(1 Suppl 1):1-225. PubMed ID: 23585445
[TBL] [Abstract][Full Text] [Related]
14. The NCI All Ireland Cancer Conference.
Johnston PG; Daly PA; Liu E
Oncologist; 1999; 4(4):275-277. PubMed ID: 10545862
[TBL] [Abstract][Full Text] [Related]
15. Treatment success in cancer: new cancer treatment successes identified in phase 3 randomized controlled trials conducted by the National Cancer Institute-sponsored cooperative oncology groups, 1955 to 2006.
Djulbegovic B; Kumar A; Soares HP; Hozo I; Bepler G; Clarke M; Bennett CL
Arch Intern Med; 2008 Mar; 168(6):632-42. PubMed ID: 18362256
[TBL] [Abstract][Full Text] [Related]
16. Economic Evaluations in National Cancer Institute-Sponsored Network Cancer Clinical Trials.
Nghiem VT; Vaidya R; Lyman GH; Hershman DL; Ramsey SD; Unger JM
Value Health; 2020 Dec; 23(12):1653-1661. PubMed ID: 33248521
[TBL] [Abstract][Full Text] [Related]
17. Effect of a US National Institutes of Health programme of clinical trials on public health and costs.
Johnston SC; Rootenberg JD; Katrak S; Smith WS; Elkins JS
Lancet; 2006 Apr; 367(9519):1319-27. PubMed ID: 16631910
[TBL] [Abstract][Full Text] [Related]
18. Analysis of Maryland cancer patient participation in national cancer institute-supported cancer treatment clinical trials.
Baquet CR; Ellison GL; Mishra SI
J Clin Oncol; 2008 Jul; 26(20):3380-6. PubMed ID: 18612153
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
